Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04210089 · ClinicalTrials.gov registry record · NA

Total Contact Soft Cast in Diabetic Foot Ulcers

A NA study of Diabetes Mellitus and Diabetic Foot Ulcer, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04210089: Recruiting NA study of Diabetes Mellitus and Diabetic Foot Ulcer, sponsored by University of Minnesota.

NCT04210089 is a NA study of Diabetes Mellitus and Diabetic Foot Ulcer that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 100 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04210089, a NA study of Diabetes Mellitus and Diabetic Foot Ulcer, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

To determine the effectiveness, compliance, patient tolerance, ease of use and safety of total contact soft cast in diabetic foot ulcers.

Primary Outcome

Complete healing is defined as complete epithelization of the ulcer. Outcome will be reported in days.

Interventions

  • DEVICE Total Contact Soft Cast
  • DEVICE Cam Boot

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-10-13
Est. Completion 2026-10-01
Phase NA
University of Minnesota

966 total trials

What NCT04210089 shows while recruiting

NCT04210089 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower).

The record links to 8 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Total Contact Soft Cast is the first listed.

NCT04210089 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04210089 about?

NCT04210089 is a clinical study titled "Total Contact Soft Cast in Diabetic Foot Ulcers". To determine the effectiveness, compliance, patient tolerance, ease of use and safety of total contact soft cast in diabetic foot ulcers.

What is the current status of trial NCT04210089?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-10-13. Estimated completion is 2026-10-01.

What conditions does trial NCT04210089 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Diabetic Foot Ulcer, Ulcer, Foot Ulcer, Ulcer Foot.

What interventions are being tested in trial NCT04210089?

The interventions under investigation include: Total Contact Soft Cast (DEVICE), Cam Boot (DEVICE).

Who is sponsoring clinical trial NCT04210089?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04210089 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04210089's enrollment target sits among peer trials

100 118th of 208 higher than 86 of 208 other Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04210089, the US trial registry maintained by the National Library of Medicine. NCT04210089 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.